Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sun Pharmaceutical Moves To Buy Taro In $450 Million Deal

This article was originally published in PharmAsia News

Executive Summary

Sun Pharmaceutical has signed a definitive agreement to acquire Haifa, Israel-based Taro Pharmaceutical Industries in a deal valued at more than $450 million, the companies announced May 21
Advertisement

Related Content

Sun Pharma Extends Offer For Taro Shares In Ongoing Rocky Affair
Sun Pharma Extends Offer For Taro Shares In Ongoing Rocky Affair
Sun Pharma Buys Additional Stake In Taro, Will Tender Offer Follow?
Sun Pharma Buys Additional Stake In Taro, Will Tender Offer Follow?
Sun Pharmaceutical To Start Generic Protonix Sales in U.S.
Sun Pharmaceutical To Start Generic Protonix Sales in U.S.
Advertisement
UsernamePublicRestriction

Register

SC066225

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel